Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm: Ana Stankovic

Fluidigm has appointed Ana Stankovic to its board of directors. Stankovic is currently managing partner at Koliada Consulting, a firm focused on biotech, medical devices, and in vitro diagnostics. Previously, she was senior vice president for worldwide regional medical affairs and global health at Becton Dickinson. She served in senior roles at BD for more than a decade, leading medical affairs and clincal operations for various BD units. Prior to this, Stankovic was an associate clinical professor in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University School of Medicine. She also served for two years as a guest lecturer in the Department of Pathology at Harvard Medical School, and is a former chief resident in the Department of Pathology at the University of Alabama at Birmingham.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.